Lusutrombopag (Mulpleta) is a small molecule agonist of the thrombopoietin receptor used to raise platelet counts in thrombocytopenic chronic liver disease patients before planned surgical procedures. Its research applications include in vitro studies of megakaryocyte proliferation and in vivo models of thrombocytopenia, supporting investigations into hematopoiesis and hemostasis management.
